MicroRNAs (miRNAs) and long non-coding RNAs (lncRNAs) as new tools for cancer therapy: first steps from bench to bedside

M Ratti, A Lampis, M Ghidini, M Salati, MB Mirchev… - Targeted …, 2020 - Springer
Non-coding RNAs represent a significant proportion of the human genome. After having
been considered as 'junk'for a long time, non-coding RNAs are now well established as …

MicroRNA-155: a master regulator of inflammation

G Mahesh, R Biswas - Journal of Interferon & Cytokine Research, 2019 - liebertpub.com
MicroRNAs (miRNAs) are naturally occurring, highly conserved families of transcripts (∼ 22
nucleotides in length) that are processed from larger hairpin precursors. miRNAs primarily …

microRNA therapeutics in cancer—an emerging concept

MY Shah, A Ferrajoli, AK Sood, G Lopez-Berestein… - …, 2016 - thelancet.com
MicroRNAs (miRNAs) are an evolutionarily conserved class of small, regulatory non-coding
RNAs that negatively regulate protein coding gene and other non-coding transcripts …

Cobomarsen, an oligonucleotide inhibitor of miR‐155, co‐ordinately regulates multiple survival pathways to reduce cellular proliferation and survival in cutaneous T …

AG Seto, X Beatty, JM Lynch… - British journal of …, 2018 - Wiley Online Library
Summary miR‐155, a microRNA associated with poor prognosis in lymphoma and
leukaemia, has been implicated in the progression of mycosis fungoides (MF), the most …

Microsatellite instability in gastric cancer: molecular bases, clinical perspectives, and new treatment approaches

M Ratti, A Lampis, JC Hahne, R Passalacqua… - Cellular and Molecular …, 2018 - Springer
Gastric cancer is one of the most aggressive malignancies, with limited treatment options in
both locally advanced and metastatic setting, resulting in poor prognosis. Based on genomic …

Balancing repair and tolerance of DNA damage caused by alkylating agents

D Fu, JA Calvo, LD Samson - Nature Reviews Cancer, 2012 - nature.com
Alkylating agents constitute a major class of frontline chemotherapeutic drugs that inflict
cytotoxic DNA damage as their main mode of action, in addition to collateral mutagenic …

Mismatch repair deficiency and response to immune checkpoint blockade

V Lee, A Murphy, DT Le, LA Diaz Jr - The oncologist, 2016 - academic.oup.com
More than 1.6 million new cases of cancer will be diagnosed in the US in 2016, resulting in
more than 500,000 deaths. Although chemotherapy has been the mainstay of treatment in …

Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma

IA Babar, CJ Cheng, CJ Booth… - Proceedings of the …, 2012 - National Acad Sciences
MicroRNA-155 (miR-155) is an oncogenic microRNA that regulates several pathways
involved in cell division and immunoregulation. It is overexpressed in numerous cancers, is …

MicroRNAs in common human diseases

Y Li, KV Kowdley - Genomics, Proteomics and Bioinformatics, 2012 - academic.oup.com
MicroRNAs (miRNAs) are a class of short non-coding RNA molecules that have attracted
tremendous attention from the biological and biomedical research communities over the …

[HTML][HTML] Epigenetic mechanisms and the hallmarks of cancer: An intimate affair

N Darwiche - American journal of cancer research, 2020 - ncbi.nlm.nih.gov
Epigenetic mechanisms comprising DNA methylation, histone modifications, and noncoding
RNAs affect chromatin structure and regulate gene expression. These mechanisms control …